tirzepatide 503a Navigating Uncertainty in Compounding – Current Status for and 503B Compliance Compounded Tirzepatide Injections $100 |

Originally developed to help cancer patients, it is now widely used for other conditions that cause nausea, including those related to weight loss treatments like semaglutide

Overpromising results: Suppliers claiming "lose 30 pounds in 30 days" are either lying or selling something dangerous

If you suspect an adverse reaction to Ozempic, you can report this through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk

The Hims/Novo Nordisk Settlement On March 9, 2026, Novo Nordisk and Hims & Hers announced a settlement

Zero human studies

But also when we put people on such a significant caloric deficit, that also starts to have negative impact on their hormones, like their thyroid